CLOs on the Move

Adverum

www.adverum.com

 
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.adverum.com
  • 800 Saginaw Drive
    Redwood City, CA USA 94063
  • Phone: 650.656.9323

Executives

Name Title Contact Details
Peter Soparkar
 Chief Legal Officer Profile
Peter Soparkar
 Chief Operating Officer Profile

Similar Companies

Becton Dickinson and Company

Becton Dickinson & Company is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diosynth

Diosynth is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

64x Bio

64x Bio is transforming the future of cell and gene therapy manufacturing with high throughput discovery and design of enhanced cell lines for next-generation biomanufacturing and therapeutics.

Cytonome

Cytonome is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aderans Research

Aderans Research is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.